Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson's disease.

Coletto E, Dolan JS, Pritchard S, Gant A, Hikima A, Jackson MJ, Benham CD, Chaudhuri KR, Rose S, Jenner P, Iravani MM.

NPJ Parkinsons Dis. 2019 Jun 10;5:10. doi: 10.1038/s41531-019-0081-9. eCollection 2019.

2.

Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson's.

Hurt CS, Rixon L, Chaudhuri KR, Moss-Morris R, Samuel M, Brown RG.

Parkinsonism Relat Disord. 2019 Apr 20. pii: S1353-8020(19)30209-3. doi: 10.1016/j.parkreldis.2019.04.014. [Epub ahead of print]

PMID:
31036430
3.

Should there be less emphasis on levodopa-induced dyskinesia in Parkinson's disease?

Chaudhuri KR, Jenner P, Antonini A.

Mov Disord. 2019 Jun;34(6):816-819. doi: 10.1002/mds.27691. Epub 2019 Apr 14. No abstract available.

PMID:
30983023
4.

Pilot Study of the International Parkinson and Movement Disorder Society-sponsored Non-motor Rating Scale (MDS-NMS).

Martinez-Martin P, Schrag A, Weintraub D, Rizos A, Rodriguez-Blazquez C, Chaudhuri KR; IPMDS Non Motor PD Study Group.

Mov Disord Clin Pract. 2019 Feb 5;6(3):227-234. doi: 10.1002/mdc3.12728. eCollection 2019 Mar.

PMID:
30949554
5.

Slave to the rhythm: Seasonal differences in non-motor symptoms in Parkinson's disease.

van Wamelen DJ, Podlewska AM, Leta V, Śmiłowska K, Rizos A, Martinez-Martin P, Bloem BR, Chaudhuri KR.

Parkinsonism Relat Disord. 2019 Jun;63:73-76. doi: 10.1016/j.parkreldis.2019.02.041. Epub 2019 Feb 28.

PMID:
30867088
6.

Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease.

Martinez-Martin P, Rizos AM, Wetmore JB, Antonini A, Odin P, Pal S, Sophia R, Carroll C, Martino D, Falup-Pecurariu C, Kessel B, Andrews T, Paviour D, Trenkwalder C, Chaudhuri KR; EUROPAR & MDS Non‐Motor PD Study Group.

Mov Disord Clin Pract. 2018 Nov 8;6(1):57-64. doi: 10.1002/mdc3.12694. eCollection 2019 Jan.

PMID:
30746417
7.

Dietary Variations in a Multiethnic Parkinson's Disease Cohort and Possible Influences on Nonmotor Aspects: A Cross-Sectional Multicentre Study.

Sauerbier A, Schrag A, Martinez-Martin P, Hall LJ, Parry M, Mischley LK, Zis P, Chaudhuri KR.

Parkinsons Dis. 2018 Dec 18;2018:7274085. doi: 10.1155/2018/7274085. eCollection 2018.

8.

Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson's Disease.

van Wamelen DJ, Grigoriou S, Chaudhuri KR, Odin P.

J Parkinsons Dis. 2018;8(s1):S65-S72. doi: 10.3233/JPD-181476.

9.

Levodopa-carbidopa intestinal gel in a subgroup of patients with dyskinesia at baseline from the GLORIA Registry.

Poewe W, Chaudhuri KR, Bergmann L, Antonini A.

Neurodegener Dis Manag. 2019 Feb;9(1):39-46. doi: 10.2217/nmt-2018-0034. Epub 2018 Dec 14.

10.

Management Recommendations on Sleep Disturbance of Patients with Parkinson's Disease.

Liu CF, Wang T, Zhan SQ, Geng DQ, Wang J, Liu J, Shang HF, Wang LJ, Chan P, Chen HB, Chen SD, Wang YP, Zhao ZX, Chaudhuri KR.

Chin Med J (Engl). 2018 Dec 20;131(24):2976-2985. doi: 10.4103/0366-6999.247210. No abstract available.

11.

Evaluation of nocturnal hypokinesia in Parkinson's disease using a novel patient/proxy questionnaire and correlations with objective monitoring.

Bhidayasiri R, Phokaewvarangkul O, Sringean J, Martinez-Martin P, Anan C, Kantachadvanich N, Chaudhuri KR, Hattori N.

Parkinsonism Relat Disord. 2019 Apr;61:219-223. doi: 10.1016/j.parkreldis.2018.09.023. Epub 2018 Sep 21.

PMID:
30314847
12.

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial.

Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A.

Lancet Neurol. 2018 Sep;17(9):749-759. doi: 10.1016/S1474-4422(18)30239-4. Epub 2018 Jul 25.

PMID:
30055903
13.

Assessment and Management of Neuropsychiatric Symptoms in Parkinson's Disease.

Mueller C, Rajkumar AP, Wan YM, Velayudhan L, Ffytche D, Chaudhuri KR, Aarsland D.

CNS Drugs. 2018 Jul;32(7):621-635. doi: 10.1007/s40263-018-0540-6.

PMID:
30027401
14.

Noninvasive options for 'wearing-off' in Parkinson's disease: a clinical consensus from a panel of UK Parkinson's disease specialists.

Fackrell R, Carroll CB, Grosset DG, Mohamed B, Reddy P, Parry M, Chaudhuri KR, Foltynie T.

Neurodegener Dis Manag. 2018 Oct;8(5):349-360. doi: 10.2217/nmt-2018-0020. Epub 2018 Jul 5.

15.

A noninterventional study evaluating the effectiveness of rotigotine and levodopa combination therapy in younger versus older patients with Parkinson's disease.

Woitalla D, Dunac A, Safavi A, Ceravolo MG, Gomez Esteban JC, Pavese N, Asgharnejad M, Joeres L, Schuller JC, Chaudhuri KR.

Expert Opin Pharmacother. 2018 Jun;19(9):937-945. doi: 10.1080/14656566.2018.1480721. Epub 2018 Jun 19.

PMID:
29916262
16.

A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease.

Silverdale MA, Kobylecki C, Kass-Iliyya L, Martinez-Martin P, Lawton M, Cotterill S, Chaudhuri KR, Morris H, Baig F, Williams N, Hubbard L, Hu MT, Grosset DG; UK Parkinson's Pain Study Collaboration.

Parkinsonism Relat Disord. 2018 Nov;56:27-32. doi: 10.1016/j.parkreldis.2018.06.001. Epub 2018 Jun 6.

17.

Exploring Bedroom Usability and Accessibility in Parkinson's Disease (PD): The Utility of a PD Home Safety Questionnaire and Implications for Adaptations.

Bhidayasiri R, Jitkritsadakul O, Sringean J, Jantanapornchai T, Kantachadvanich N, Phumphid S, Boonpang K, Pensook S, Aungkab N, Hattori N, Chaudhuri KR.

Front Neurol. 2018 May 17;9:360. doi: 10.3389/fneur.2018.00360. eCollection 2018.

18.

Changes in Parkinson's disease sleep symptoms and daytime somnolence after bilateral subthalamic deep brain stimulation in Parkinson's disease.

Kharkar S, Ellenbogen JR, Samuel M, Rizos A, Silverdale M, Chaudhuri KR, Ashkan K.

NPJ Parkinsons Dis. 2018 May 25;4:16. doi: 10.1038/s41531-018-0053-5. eCollection 2018.

19.

Serotonergic dysregulation is linked to sleep problems in Parkinson's disease.

Wilson H, Giordano B, Turkheimer FE, Chaudhuri KR, Politis M.

Neuroimage Clin. 2018 Mar 2;18:630-637. doi: 10.1016/j.nicl.2018.03.001. eCollection 2018.

20.

First comprehensive tool for screening pain in Parkinson's disease: the King's Parkinson's Disease Pain Questionnaire.

Martinez-Martin P, Rizos AM, Wetmore J, Antonini A, Odin P, Pal S, Sophia R, Carroll C, Martino D, Falup-Pecurariu C, Kessel B, Andrews T, Paviour D, Trenkwalder C, Chaudhuri KR; EUROPAR and MDS Non-motor PD Study Group.

Eur J Neurol. 2018 Oct;25(10):1255-1261. doi: 10.1111/ene.13691. Epub 2018 Jun 22.

PMID:
29806962
21.

Non-motor Parkinson disease: new concepts and personalised management.

Titova N, Chaudhuri KR.

Med J Aust. 2018 May 21;208(9):404-409. Review.

PMID:
29764353
22.

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease.

Odin P, Chaudhuri KR, Volkmann J, Antonini A, Storch A, Dietrichs E, Pirtošek Z, Henriksen T, Horne M, Devos D, Bergquist F.

NPJ Parkinsons Dis. 2018 May 10;4:14. doi: 10.1038/s41531-018-0051-7. eCollection 2018. Review.

23.

Pain in Parkinson's disease: facts and uncertainties.

Antonini A, Tinazzi M, Abbruzzese G, Berardelli A, Chaudhuri KR, Defazio G, Ferreira J, Martinez-Martin P, Trenkwalder C, Rascol O.

Eur J Neurol. 2018 Jul;25(7):917-e69. doi: 10.1111/ene.13624. Epub 2018 Apr 18. Review.

PMID:
29520899
24.

Non motor symptoms in progressive supranuclear palsy: prevalence and severity.

Radicati FG, Martinez Martin P, Fossati C, Chaudhuri KR, Torti M, Rodriguez Blazquez C, Vacca L, Stocchi F.

NPJ Parkinsons Dis. 2017 Dec 8;3:35. doi: 10.1038/s41531-017-0037-x. eCollection 2017.

25.

The Parkinson's Disease Composite Scale: results of the first validation study.

Stocchi F, Radicati FG, Chaudhuri KR, Johansson A, Padmakumar C, Falup-Pecurariu C, Martinez-Martin P.

Eur J Neurol. 2018 Mar;25(3):503-511. doi: 10.1111/ene.13529. Epub 2018 Jan 13.

PMID:
29193455
26.

Erratum: Author Correction: Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson's disease.

Lakshminarayana R, Wang D, Burn D, Chaudhuri KR, Galtrey C, Guzman NV, Hellman B, James B, Pal S, Stamford J, Steiger M, Stott RW, Teo J, Barker RA, Wang E, Bloem BR, van der Eijk M, Rochester L, Williams A.

NPJ Parkinsons Dis. 2017 Nov 13;3:32. doi: 10.1038/s41531-017-0034-0. eCollection 2017.

27.

Advanced Parkinson's or "complex phase" Parkinson's disease? Re-evaluation is needed.

Titova N, Martinez-Martin P, Katunina E, Chaudhuri KR.

J Neural Transm (Vienna). 2017 Dec;124(12):1529-1537. doi: 10.1007/s00702-017-1799-3. Epub 2017 Nov 7. Review.

28.

Management of Psychosis in Parkinson's Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition.

Taddei RN, Cankaya S, Dhaliwal S, Chaudhuri KR.

Parkinsons Dis. 2017;2017:3256542. doi: 10.1155/2017/3256542. Epub 2017 Sep 12. Review.

29.

Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.

Pagano G, Yousaf T, Wilson H, Niccolini F, Polychronis S, Chaudhuri KR, Politis M.

Eur J Neurol. 2018 Feb;25(2):307-312. doi: 10.1111/ene.13503. Epub 2017 Dec 11.

PMID:
29078029
30.

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry.

Antonini A, Poewe W, Chaudhuri KR, Jech R, Pickut B, Pirtošek Z, Szasz J, Valldeoriola F, Winkler C, Bergmann L, Yegin A, Onuk K, Barch D, Odin P; GLORIA study co-investigators.

Parkinsonism Relat Disord. 2017 Dec;45:13-20. doi: 10.1016/j.parkreldis.2017.09.018. Epub 2017 Sep 22.

31.

Parkinson's Disease Subtypes Identified from Cluster Analysis of Motor and Non-motor Symptoms.

Mu J, Chaudhuri KR, Bielza C, de Pedro-Cuesta J, Larrañaga P, Martinez-Martin P.

Front Aging Neurosci. 2017 Sep 20;9:301. doi: 10.3389/fnagi.2017.00301. eCollection 2017.

32.

The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson's disease.

Lowin J, Sail K, Baj R, Jalundhwala YJ, Marshall TS, Konwea H, Chaudhuri KR.

J Med Econ. 2017 Nov;20(11):1207-1215. doi: 10.1080/13696998.2017.1379411. Epub 2017 Sep 21.

PMID:
28895769
33.

Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now?

Rosa-Grilo M, Qamar MA, Taddei RN, Pagonabarraga J, Kulisevsky J, Sauerbier A, Chaudhuri KR.

NPJ Parkinsons Dis. 2017 Sep 5;3:28. doi: 10.1038/s41531-017-0030-4. eCollection 2017. Review.

34.

Identifying barriers to help-seeking for non-motor symptoms in people with Parkinson's disease.

Hurt CS, Rixon L, Chaudhuri KR, Moss-Morris R, Samuel M, Brown RG.

J Health Psychol. 2019 Apr;24(5):561-571. doi: 10.1177/1359105316683239. Epub 2016 Dec 1.

PMID:
28810364
35.

Nonmotor Parkinson's and Future Directions.

Titova N, Chaudhuri KR.

Int Rev Neurobiol. 2017;134:1493-1505. doi: 10.1016/bs.irn.2017.05.017. Epub 2017 Jul 4. Review.

PMID:
28805581
36.

Personalized Medicine and Nonmotor Symptoms in Parkinson's Disease.

Titova N, Chaudhuri KR.

Int Rev Neurobiol. 2017;134:1257-1281. doi: 10.1016/bs.irn.2017.05.015. Review.

PMID:
28805572
37.

Palliative Care and Nonmotor Symptoms in Parkinson's Disease and Parkinsonism.

Titova N, Chaudhuri KR.

Int Rev Neurobiol. 2017;134:1239-1255. doi: 10.1016/bs.irn.2017.05.014. Epub 2017 Jul 4. Review.

PMID:
28805571
38.

Letter to the editor: Automated night-time deep brain stimulation battery checks can induce symptoms: Identification and management of a new hardware complication.

Klingelhoefer L, Hulse N, Chaudhuri KR, Ashkan K, Samuel M.

Brain Stimul. 2017 Nov - Dec;10(6):1148-1149. doi: 10.1016/j.brs.2017.07.014. Epub 2017 Aug 2. No abstract available.

PMID:
28803833
39.

Nonmotor Symptoms in Experimental Models of Parkinson's Disease.

Titova N, Schapira AHV, Chaudhuri KR, Qamar MA, Katunina E, Jenner P.

Int Rev Neurobiol. 2017;133:63-89. doi: 10.1016/bs.irn.2017.05.018. Epub 2017 Jul 10. Review.

PMID:
28802936
40.

Nonmotor Subtyping in Parkinson's Disease.

Sauerbier A, Rosa-Grilo M, Qamar MA, Chaudhuri KR.

Int Rev Neurobiol. 2017;133:447-478. doi: 10.1016/bs.irn.2017.05.011. Epub 2017 Jul 13. Review.

PMID:
28802928
41.

Two hundred years since James Parkinson's essay on the shaking palsy-Have we made progress? Insights from the James Parkinson's 200 years course held in London, March 2017.

Chaudhuri KR, Jenner P.

Mov Disord. 2017 Sep;32(9):1311-1315. doi: 10.1002/mds.27104. Epub 2017 Aug 11. Review. No abstract available.

PMID:
28799259
42.

Depression and Catechol-O-methyltransferase (COMT) genetic variants are associated with pain in Parkinson's disease.

Lin CH, Chaudhuri KR, Fan JY, Ko CI, Rizos A, Chang CW, Lin HI, Wu YR.

Sci Rep. 2017 Jul 24;7(1):6306. doi: 10.1038/s41598-017-06782-z.

43.

Non-motor features of Parkinson disease.

Schapira AHV, Chaudhuri KR, Jenner P.

Nat Rev Neurosci. 2017 Aug;18(8):509. doi: 10.1038/nrn.2017.91. Epub 2017 Jul 13.

PMID:
28720825
44.

A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement.

de Roos P, Bloem BR, Kelley TA, Antonini A, Dodel R, Hagell P, Marras C, Martinez-Martin P, Mehta SH, Odin P, Chaudhuri KR, Weintraub D, Wilson B, Uitti RJ.

J Parkinsons Dis. 2017;7(3):533-543. doi: 10.3233/JPD-161055.

45.

Distribution and impact on quality of life of the pain modalities assessed by the King's Parkinson's disease pain scale.

Martinez-Martin P, Manuel Rojo-Abuin J, Rizos A, Rodriguez-Blazquez C, Trenkwalder C, Perkins L, Sauerbier A, Odin P, Antonini A, Chaudhuri KR; KPPS, EUROPAR and the IPMDS Non Motor PD Study Group.

NPJ Parkinsons Dis. 2017 Mar 15;3:8. doi: 10.1038/s41531-017-0009-1. eCollection 2017.

46.

Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?

Qamar MA, Sauerbier A, Politis M, Carr H, Loehrer P, Chaudhuri KR.

NPJ Parkinsons Dis. 2017 Jan 25;3:5. doi: 10.1038/s41531-016-0006-9. eCollection 2017.

47.

Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson's disease.

Lakshminarayana R, Wang D, Burn D, Chaudhuri KR, Galtrey C, Guzman NV, Hellman B, Ben James, Pal S, Stamford J, Steiger M, Stott RW, Teo J, Barker RA, Wang E, Bloem BR, van der Eijk M, Rochester L, Williams A.

NPJ Parkinsons Dis. 2017 Jan 9;3:2. doi: 10.1038/s41531-016-0003-z. eCollection 2017. Erratum in: NPJ Parkinsons Dis. 2017 Nov 13;3:32.

48.

A new tool to identify patients with Parkinson's disease at increased risk of dementia.

Aarsland D, Creese B, Chaudhuri KR.

Lancet Neurol. 2017 Aug;16(8):576-578. doi: 10.1016/S1474-4422(17)30170-9. Epub 2017 Jun 16. No abstract available. Erratum in: Lancet Neurol. 2017 Aug;16(8):584.

PMID:
28629880
49.

Personalized medicine in Parkinson's disease: Time to be precise.

Titova N, Chaudhuri KR.

Mov Disord. 2017 Aug;32(8):1147-1154. doi: 10.1002/mds.27027. Epub 2017 Jun 12. No abstract available.

50.

Non-motor features of Parkinson disease.

Schapira AHV, Chaudhuri KR, Jenner P.

Nat Rev Neurosci. 2017 Jul;18(7):435-450. doi: 10.1038/nrn.2017.62. Epub 2017 Jun 8. Review. Erratum in: Nat Rev Neurosci. 2017 Aug;18(8):509.

PMID:
28592904

Supplemental Content

Loading ...
Support Center